UBS Maintains Buy on Vylor, Lowers Price Target to $87
Vylor Files Shelf Prospectus For Offering; Size Not Disclosed
Vylor Inc. (VYLR) Q3 2026 Earnings Call Transcript
Vylor Q3 2026 Earnings Call Transcript
Vylor Reaffirms Full-Year Guidance on Strong YTD Results, Advances Leading Technology
Vylor Sees FY2026 Adj EPS $2.25-$2.35 vs $2.30 Est
Vylor Q3 Adj. EPS $(0.42) Beats $(0.50) Estimate, Sales $938.000M Beat $903.652M Estimate
Is Wall Street Bullish or Bearish on Vylor Stock?
32 ETFs Add to Vylor (VYLR) on Nov. 5
Why Vylor (VYLR) Is Getting Attention Today
Vylor (VYLR) Stock Could Be 34% Below Fair Value Following $3b Buyback Plan
Vylor Declares Quarterly Dividend
Vylor Announces $3 Billion Share Repurchase Program
Vylor Announces $3B Buyback Plan
This Entegris Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
BNP Paribas Initiates Coverage On Vylor with Neutral Rating, Announces Price Target of $75
Vylor: A Food Scarcity Play With Growth Optionality
UBS Initiates Coverage On Vylor with Buy Rating, Announces Price Target of $89
Jim Cramer Gives Green Light To This Health Care Stock
Goldman Sachs Initiates Coverage On Vylor with Buy Rating, Announces Price Target of $87
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.